Number of people with Alzheimer’s is increasing day-by-day and death rate is also getting severe. Every sixty six seconds there is a new patient diagnosed with Alzheimer’s disease. Scientists have better understanding of pathophysiology for Alzheimer’s disease by clinical trials.
Alzheimer’s patients should participate in this study for the treatment and cure of this disease that will be great offering for the society and for those who are suffering from Alzheimer’s.
We can slow down Alzheimer’s disease in its early stages, if its symptoms are recognized at its early days. In clinical trials, scientists target the patients with early dementia stage where the prevention is possible. While at the sever stage of Alzheimer’s disease, nothing can be done.
Alzheimer’s disease has become one of the top death causing diseases. We should find better opportunities to understand the action of disease and the medication for targeting the proteins which cause Alzheimer’s disease. The patients of Alzheimer’s disease should participate in clinical trials for a better quality of life for themselves and for their care takers. These clinical trials can last up to two years.
There are certain complications that come with Alzheimer’s disease as perspiration, pneumonia as the patient cannot take care of themselves, they cannot feed themselves, cannot take care of their needs and the Patient die due to these complications. Alzheimer’s disease is not a part of normal aging, it is a pathological condition.